SPRB – spruce biosciences, inc. (US:NASDAQ)
Stock Stats
News
Spruce Biosciences Secures Up to $50 Million in Growth Capital from Avenue Capital
Spruce Biosciences (NASDAQ:SPRB) was downgraded by analysts at Wall Stre
Spruce Biosciences (NASDAQ:SPRB) is now covered by analysts at Oppenheimer Holdings, Inc.. They set an "outperform" rating on the stock.
Spruce Biosciences (NASDAQ:SPRB) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $220.00 price target on the stock.
Spruce Biosciences Appoints Proven Pharmaceutical Commercial Leader Keli Walbert to Board of Directors [Yahoo! Finance]
Form 8-K SPRUCE BIOSCIENCES, INC. For: Jan 07
Form 4 SPRUCE BIOSCIENCES, INC. For: Dec 31 Filed by: Szwarcberg Javier B.
Form 4 SPRUCE BIOSCIENCES, INC. For: Dec 15 Filed by: Gharib Samir M.
Form 4 SPRUCE BIOSCIENCES, INC. For: Dec 11 Filed by: Szwarcberg Javier B.
Form 4 SPRUCE BIOSCIENCES, INC. For: Dec 11 Filed by: SPIEGELMAN DANIEL K
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.